On the recordNovember 16, 2015
FDA has two opportunities. One is to issue guidance letters. The other is to do rulemaking.
Source
congress.govEditor's note · Context
Isakson explains the difference between guidance letters and rulemaking.
Share
More from Johnny Isakson
Dec 11, 2019
I always come to the well of the Senate with a purpose. I try not to talk too long, and I try to make my point and get out before I make a big mistake. When you are saying thank you to people who have done so much for you, it is almost…
Nov 13, 2019
Reserving the right to object, I want to say to my committee member how much I appreciate his dedicated work. In the committee, we work on a lot of things, including the diseases in here, getting presumptive conclusions done so we can…
Sep 9, 2019
I rise for a moment to pay tribute to a great Georgian and his wife who this past Saturday in Athens, GA, before the University of Georgia football game, were honored by naming the field at the Sanford Stadium, Dooley Field. Vince Dooley…
Nov 12, 2019
today I would like to remember in the Record former U.S. Senator Kay Hagan of North Carolina. Senator Hagan and I served together on the Senate Committee on Health, Education, Labor, and Pensions, where she served both North Carolina and…
Other voices in this conversation
